Skip to content

PROSTATE ONCOLOGY SPECIALISTS

P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM

Menu
  • About
  • Services
  • Prostate Pros
  • Blog
  • Contact

Category: Low Risk

Sky (Low-Risk) is a relatively harmless condition. The biggest risk for Sky is overtreatment. Within Sky, the most favorable subtype of all (Low-Sky) is defined by all the usual Sky criteria of Gleason 3+3=6, PSA less than 10 and minimal or no palpable disease on DRE. In addition, to qualify as Low-Sky, the PSA density must be less than 0.15, there can be no more than two biopsy cores containing cancer and no single core can be more than 50 percent involved. Men in Low-Sky have the best chance for staying on surveillance long term without requiring treatment. At the other end of the spectrum (within Sky) is High-Sky which is defined by all the usual Sky criteria but with one or more of the following: palpable disease, a PSA density over 0.15 or more than 50% of the biopsy cores containing cancer. These men are at somewhat greater risk for disease progression, i.e., the eventual need to go off active surveillance and undergo treatment. Basic-Sky falls between the Low and High subtypes. As would be expected, the risk for men with Basic-Sky to require future treatment is intermediate between Low and High.

Verywell logo
Low Risk / Newly Diagnosed / Prostate Cancer / Undiagnosed

The UnCancer: What is the Gleason 6 Type in Prostate Cancer?

BY MARK SCHOLZ, MD At the first ever Active Surveillance Convention, a conference I attended back in 2007, many experts openly bemoaned that the word “CANCER” profoundly overstates the significance …

Verywell logo
High Risk / Intermediate Risk / Low Risk / Prostate Cancer / Relapsed

When PSA Doubling Time Shows a Prostate Cancer Relapse in Men

BY MARK SCHOLZ, MD One cannot really talk intelligently about prostate cancer without a working knowledge of the PSA blood test.  Most people are familiar with using PSA to diagnose prostate …

Elevated / Low Risk / Newly Diagnosed / Prostate Cancer

Prostate Size Matters

BY MARK SCHOLZ, MD Everyone seems to think that a large prostate is bad.  Large glands get blamed for just about any abnormal urinary symptom that occurs: discomfort, slow urination, frequent urination, …

Advanced / High Risk / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed

What about Sex after Prostate Surgery?

BY MARK SCHOLZ, MD Only 5-15% of men describe their sexual function as “undiminished” after prostate cancer surgery.[1] And I’ll venture that 0% describe it as improved. If you accept any degree …

Posts navigation

Newer posts

SCHEDULE AN APPOINTMENT

PHONE 310-827-7707
FAX 310-574-4002
mail@prostateoncology.com

  • New Patient Application
  • Education
  • Clinical Trials

Categories

  • Advanced
  • Elevated
  • High Risk
  • Intermediate Risk
  • Low Risk
  • Newly Diagnosed
  • Other
  • Prostate Cancer
  • Relapsed
  • Stages
    • Azure
    • Indigo
    • Royal
    • Sky
    • Teal
  • Undiagnosed

Recent Posts

  • PSA Screening Flowchart
  • A Few Thoughts on Prostatitis
  • Considering Prostate Cancer Clinical Trials? Here’s What You Need to Know
  • Prostate Cancer Spotlights in 2020: A Year in Review
  • Find out about PSMA PET Imaging on Prostate Pros Podcast

Archives

  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • March 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • May 2017
  • February 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • May 2016
  • April 2016
  • February 2016
  • January 2016
  • October 2015
  • November 2012
  • January 2012
  • April 2011
Join our Newsletter
Keep Updated
Copyright © 2025 PROSTATE ONCOLOGY SPECIALISTS – OnePress theme by FameThemes